Form 4 for APRE Aprea Therapeutics, Inc.
Accepted 2024-10-25 00:00:00 ET · period of report 2024-10-18 · accession 0001104659-24-111548 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-25 | 2024-10-18 | APRE | Duey Marc | Dir | S - Sale | $4.58 | -6,462 | 233.7K | -3% | -$29.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-18 | S | D | 6,462 | $4.58 | 233,651 | D | — | — | (F2) These shares were sold in multiple transactions on October 18, 2024, each at $4.578 per share. |